Chandrananimycin A is a natural product classified as an alkaloid, derived from certain microbial sources, particularly from the genus *Streptomyces*. It exhibits notable biological activity, particularly as an antimicrobial agent, and has garnered interest for its potential therapeutic applications. The compound is characterized by its complex molecular structure, which includes multiple functional groups that contribute to its reactivity and biological interactions. Chandrananimycin A has been studied for its mechanism of action, which may involve interference with cellular processes in target organisms. Its unique chemical properties, including solubility and stability, are influenced by its molecular configuration. Research into Chandrananimycin A continues to explore its efficacy against various pathogens and its potential role in drug development, particularly in the context of antibiotic resistance. As with many natural products, the extraction and synthesis of Chandrananimycin A pose challenges, but advancements in synthetic methodologies may enhance its availability for research and therapeutic use.

Chandrananimycin A

664355-12-8: Chandrananimycin A is a natural product classified as an alkaloid, derived from certain microbial sources, particularly from the genus *Streptomyces*. It exhibits notable biological activity, particularly as an antimicrobial agent, and has garnered interest for its potential therapeutic applications. The compound is characterized by its complex molecular structure, which includes multiple functional groups that contribute to its reactivity and biological interactions. Chandrananimycin A has been studied for its mechanism of action, which may involve interference with cellular processes in target organisms. Its unique chemical properties, including solubility and stability, are influenced by its molecular configuration. Research into Chandrananimycin A continues to explore its efficacy against various pathogens and its potential role in drug development, particularly in the context of antibiotic resistance. As with many natural products, the extraction and synthesis of Chandrananimycin A pose challenges, but advancements in synthetic methodologies may enhance its availability for research and therapeutic use.

<p>Chandrananimycin A exhibits activity against Mucorales fungi and shows efficacy against tumor cell lines such as CCL HT29, MFXF 529L, and MACL McF-7.</p>

CAS 664355-12-8

Chandrananimycin A

Chandrananimycin A

Ref: TM-TN9902